Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.25 USD | +1.47% | +3.23% | -44.91% |
04-30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- MarketScreener Strategies